Heart Alert starts to sell over-the-counter (otc) cardiac monitor:
This article was originally published in Clinica
Heart Alert is test-marketing its PHD Personal Heart Device over the counter in the Tampa Bay area of Florida. Heart Alert, received 510(k) clearance in May for the system, which allows subscribers to record symptomatic heart rhythms and transmit them to Heart Alert's monitoring service of physicians, nurses and technicians. They in turn alert the patient's own physician or the emergency services if abnormal heart rhythms are observed.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.